{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:21:52Z","timestamp":1783045312313,"version":"3.54.6"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2023ZD0509100"],"award-info":[{"award-number":["2023ZD0509100"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200933"],"award-info":[{"award-number":["82200933"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019081","name":"Science and Technology Program of Hunan Province","doi-asserted-by":"publisher","award":["2024RC3054"],"award-info":[{"award-number":["2024RC3054"]}],"id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03203-2","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T13:35:03Z","timestamp":1778333703000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative proteogenomic and observational analysis identifies potential biomarkers for latent autoimmune diabetes in adults"],"prefix":"10.1186","volume":"25","author":[{"given":"Yuanqin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruofan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"issue":"10","key":"3203_CR1","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.2337\/dbi20-0017","volume":"69","author":"R Buzzetti","year":"2020","unstructured":"Buzzetti R, Tuomi T, Mauricio D, Pietropaolo M, Zhou Z, Pozzilli P, et al. Management of Latent Autoimmune Diabetes in Adults: a consensus statement from an international expert panel. Diabetes. 2020;69(10):2037\u201347.","journal-title":"Diabetes"},{"issue":"9","key":"3203_CR2","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.tem.2018.07.001","volume":"29","author":"R Mishra","year":"2018","unstructured":"Mishra R, Hodge KM, Cousminer DL, Leslie RD, Grant SFA. A global perspective of Latent Autoimmune Diabetes in Adults. Trends Endocrinol Metab. 2018;29(9):638\u201350.","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"3203_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41572-022-00390-6","volume":"8","author":"R Buzzetti","year":"2022","unstructured":"Buzzetti R, Maddaloni E, Gaglia J, Leslie RD, Wong FS, Boehm BO. Adult-onset autoimmune diabetes. Nat Rev Dis Primers. 2022;8(1):63.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"3203_CR4","doi-asserted-by":"publisher","first-page":"260","DOI":"10.4093\/dmj.2019.0007","volume":"44","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Qian L, Liu Q, Zou J, Zhou Y, Yang T, et al. Glutamic acid decarboxylase autoantibody detection by electrochemiluminescence assay identifies latent autoimmune diabetes in adults with poor islet function. Diabetes Metab J. 2019;44(2):260\u20136.","journal-title":"Diabetes Metab J"},{"issue":"9","key":"3203_CR5","doi-asserted-by":"publisher","first-page":"942","DOI":"10.15252\/msb.20156297","volume":"13","author":"PE Geyer","year":"2017","unstructured":"Geyer PE, Holdt LM, Teupser D, Mann M. Revisiting biomarker discovery by plasma proteomics. Mol Syst Biol. 2017;13(9):942.","journal-title":"Mol Syst Biol"},{"issue":"1","key":"3203_CR6","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s13098-024-01479-6","volume":"16","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Xu M, Xiong P, Yuan J, Zheng D, Piao S. Prognosis and outcome of latent autoimmune diabetes in adults: T1DM or T2DM? Diabetol Metab Syndr. 2024;16(1):242.","journal-title":"Diabetol Metab Syndr"},{"issue":"7","key":"3203_CR7","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1007\/s00125-011-2088-6","volume":"54","author":"MN Pham","year":"2011","unstructured":"Pham MN, Hawa MI, Pfleger C, Roden M, Schernthaner G, Pozzilli P, et al. Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, Type 1 and Type 2 diabetes patients: Action LADA 4. Diabetologia. 2011;54(7):1630\u20138.","journal-title":"Diabetologia"},{"issue":"7975","key":"3203_CR8","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41586-023-06388-8","volume":"620","author":"K Trajanoska","year":"2023","unstructured":"Trajanoska K, Bh\u00e9rer C, Taliun D, Zhou S, Richards JB, Mooser V. From target discovery to clinical drug development with human genetics. Nature. 2023;620(7975):737\u201345.","journal-title":"Nature"},{"issue":"11","key":"3203_CR9","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.2337\/dc18-1032","volume":"41","author":"DL Cousminer","year":"2018","unstructured":"Cousminer DL, Ahlqvist E, Mishra R, Andersen MK, Chesi A, Hawa MI, et al. First Genome-Wide Association Study of Latent Autoimmune Diabetes in Adults reveals novel insights linking immune and metabolic diabetes. Diabetes Care. 2018;41(11):2396\u2013403.","journal-title":"Diabetes Care"},{"issue":"1","key":"3203_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2337\/dc21-1049","volume":"45","author":"N Yazdanpanah","year":"2022","unstructured":"Yazdanpanah N, Yazdanpanah M, Wang Y, Forgetta V, Pollak M, Polychronakos C, et al. Clinically relevant circulating protein biomarkers for Type 1 Diabetes: evidence from a two-sample Mendelian randomization study. Diabetes Care. 2022;45(1):169\u201377.","journal-title":"Diabetes Care"},{"issue":"12","key":"3203_CR11","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad E, Sulem P, Atlason BA, Sveinbjornsson G, Magnusson MI, Styrmisdottir EL, et al. Large-scale integration of the plasma proteome with genetics and disease. Nat Genet. 2021;53(12):1712\u201321.","journal-title":"Nat Genet"},{"issue":"6404","key":"3203_CR12","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1126\/science.aaq1327","volume":"361","author":"V Emilsson","year":"2018","unstructured":"Emilsson V, Ilkov M, Lamb JR, Finkel N, Gudmundsson EF, Pitts R, et al. Co-regulatory networks of human serum proteins link genetics to disease. Science. 2018;361(6404):769\u201373.","journal-title":"Science"},{"issue":"6569","key":"3203_CR13","doi-asserted-by":"publisher","first-page":"eabj1541","DOI":"10.1126\/science.abj1541","volume":"374","author":"M Pietzner","year":"2021","unstructured":"Pietzner M, Wheeler E, Carrasco-Zanini J, Cortes A, Koprulu M, W\u00f6rheide MA, et al. Mapping the proteo-genomic convergence of human diseases. Science. 2021;374(6569):eabj1541.","journal-title":"Science"},{"issue":"7982","key":"3203_CR14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun BB, Chiou J, Traylor M, Benner C, Hsu Y-H, Richardson TG, et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature. 2023;622(7982):329\u201338.","journal-title":"Nature"},{"issue":"7863","key":"3203_CR15","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41586-021-03552-w","volume":"594","author":"J Chiou","year":"2021","unstructured":"Chiou J, Geusz RJ, Okino M-L, Han JY, Miller M, Melton R, et al. Interpreting type 1 diabetes risk with genetics and single-cell epigenomics. Nature. 2021;594(7863):398\u2013402.","journal-title":"Nature"},{"issue":"11","key":"3203_CR16","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/s41588-018-0241-6","volume":"50","author":"A Mahajan","year":"2018","unstructured":"Mahajan A, Taliun D, Thurner M, Robertson NR, Torres JM, Rayner NW, et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat Genet. 2018;50(11):1505\u201313.","journal-title":"Nat Genet"},{"issue":"9","key":"3203_CR17","doi-asserted-by":"publisher","first-page":"101174","DOI":"10.1016\/j.xcrm.2023.101174","volume":"4","author":"S Yuan","year":"2023","unstructured":"Yuan S, Xu F, Li X, Chen J, Zheng J, Mantzoros CS, et al. Plasma proteins and onset of type 2 diabetes and diabetic complications: proteome-wide Mendelian randomization and colocalization analyses. Cell Rep Med. 2023;4(9):101174.","journal-title":"Cell Rep Med"},{"issue":"10","key":"3203_CR18","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/s41588-020-0682-6","volume":"52","author":"J Zheng","year":"2020","unstructured":"Zheng J, Haberland V, Baird D, Walker V, Haycock PC, Hurle MR, et al. Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases. Nat Genet. 2020;52(10):1122\u201331.","journal-title":"Nat Genet"},{"issue":"383","key":"3203_CR19","doi-asserted-by":"publisher","first-page":"eaag1166","DOI":"10.1126\/scitranslmed.aag1166","volume":"9","author":"C Finan","year":"2017","unstructured":"Finan C, Gaulton A, Kruger FA, Lumbers RT, Shah T, Engmann J, et al. The druggable genome and support for target identification and validation in drug development. Sci Transl Med. 2017;9(383):eaag1166.","journal-title":"Sci Transl Med"},{"issue":"D1","key":"3203_CR20","doi-asserted-by":"publisher","first-page":"D930","DOI":"10.1093\/nar\/gky1075","volume":"47","author":"D Mendez","year":"2019","unstructured":"Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, F\u00e9lix E, et al. ChEMBL: towards direct deposition of bioassay data. Nucleic Acids Res. 2019;47(D1):D930\u201340.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"3203_CR21","doi-asserted-by":"publisher","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","volume":"52","author":"C Knox","year":"2024","unstructured":"Knox C, Wilson M, Klinger CM, Franklin M, Oler E, Wilson A, et al. DrugBank 6.0: the DrugBank Knowledgebase for 2024. Nucleic Acids Res. 2024;52(D1):D1265\u201375.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"3203_CR22","doi-asserted-by":"publisher","first-page":"D870","DOI":"10.1093\/nar\/gkac947","volume":"51","author":"C Hu","year":"2023","unstructured":"Hu C, Li T, Xu Y, Zhang X, Li F, Bai J, et al. Cell Marker 2.0: an updated database of manually curated cell markers in human\/mouse and web tools based on scRNA-seq data. Nucleic Acids Res. 2023;51(D1):D870\u20136.","journal-title":"Nucleic Acids Res"},{"key":"3203_CR23","doi-asserted-by":"publisher","first-page":"e34408","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408.","journal-title":"Elife"},{"issue":"3","key":"3203_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/gepi.20551","volume":"35","author":"R Xiao","year":"2011","unstructured":"Xiao R, Boehnke M. Quantifying and correcting for the winner\u2019s curse in quantitative-trait association studies. Genet Epidemiol. 2011;35(3):133\u20138.","journal-title":"Genet Epidemiol"},{"issue":"3","key":"3203_CR25","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.autrev.2013.10.010","volume":"13","author":"A Antonelli","year":"2014","unstructured":"Antonelli A, Ferrari SM, Giuggioli D, Ferrannini E, Ferri C, Fallahi P. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmun Rev. 2014;13(3):272\u201380.","journal-title":"Autoimmun Rev"},{"issue":"30","key":"3203_CR26","doi-asserted-by":"publisher","first-page":"e2308461","DOI":"10.1002\/advs.202308461","volume":"11","author":"X Wu","year":"2024","unstructured":"Wu X, Cheong LY, Yuan L, Jin L, Zhang Z, Xiao Y, et al. Islet-resident memory T Cells orchestrate the immunopathogenesis of type 1 diabetes through the FABP4-CXCL10 axis. Adv Sci (Weinh). 2024;11(30):e2308461.","journal-title":"Adv Sci (Weinh)"},{"key":"3203_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.trsl.2021.01.004","volume":"232","author":"SE Kang","year":"2021","unstructured":"Kang SE, Park JK, Yoo HJ, Kang H-S, Park YW, Park B-C, et al. Efficacy of novel bispecific antibody targeting TNF-\u03b1\/CXCL10 in the treatment of experimental arthritis. Transl Res. 2021;232:75\u201387.","journal-title":"Transl Res"},{"issue":"12","key":"3203_CR28","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1136\/annrheumdis-2018-213257","volume":"77","author":"C Crescioli","year":"2018","unstructured":"Crescioli C, Corinaldesi C, Riccieri V, Raparelli V, Vasile M, Del Galdo F, et al. Association of circulating CXCL10 and CXCL11 with systemic sclerosis. Ann Rheum Dis. 2018;77(12):1845\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"3203_CR29","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00125-024-06303-4","volume":"68","author":"C Santoso","year":"2025","unstructured":"Santoso C, Wei Y, Ahlqvist E, Tuomi T, Carlsson S. Autoimmune diseases and the risk and prognosis of latent autoimmune diabetes in adults. Diabetologia. 2025;68(2):331\u201341.","journal-title":"Diabetologia"},{"issue":"4","key":"3203_CR30","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00125-024-06098-4","volume":"67","author":"M Guo","year":"2024","unstructured":"Guo M, Guo H, Zhu J, Wang F, Chen J, Wan C, et al. A novel subpopulation of monocytes with a strong interferon signature indicated by SIGLEC-1 is present in patients with in recent-onset type 1 diabetes. Diabetologia. 2024;67(4):623\u201340.","journal-title":"Diabetologia"},{"key":"3203_CR31","doi-asserted-by":"publisher","first-page":"112935","DOI":"10.1016\/j.diabres.2025.112935","volume":"229","author":"AS Januszewski","year":"2025","unstructured":"Januszewski AS, Rankin WA, O\u2019Neal DN, Wittert GA, Jenkins AJ. Sex hormone binging globulin as an indicator of insulin resistance in type 1 diabetes. Diabetes Res Clin Pract. 2025;229:112935.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"3203_CR32","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/ije\/dyq158","volume":"40","author":"JS Brand","year":"2011","unstructured":"Brand JS, van der Tweel I, Grobbee DE, Emmelot-Vonk MH, van der Schouw YT. Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies. Int J Epidemiol. 2011;40(1):189\u2013207.","journal-title":"Int J Epidemiol"},{"issue":"8","key":"3203_CR33","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1007\/s00125-012-2566-5","volume":"55","author":"ZC Feng","year":"2012","unstructured":"Feng ZC, Li J, Turco BA, Riopel M, Yee SP, Wang R. Critical role of c-Kit in beta cell function: increased insulin secretion and protection against diabetes in a mouse model. Diabetologia. 2012;55(8):2214\u201325.","journal-title":"Diabetologia"},{"issue":"16","key":"3203_CR34","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1242\/dev.098533","volume":"140","author":"GR Diaferia","year":"2013","unstructured":"Diaferia GR, Jimenez-Caliani AJ, Ranjitkar P, Yang W, Hardiman G, Rhodes CJ, et al. \u03b21 integrin is a crucial regulator of pancreatic \u03b2-cell expansion. Development. 2013;140(16):3360\u201372.","journal-title":"Development"},{"issue":"5","key":"3203_CR35","doi-asserted-by":"publisher","first-page":"4566","DOI":"10.1007\/s10528-024-10926-y","volume":"63","author":"F Lu","year":"2025","unstructured":"Lu F, Ding L, Qiao Y. APEX1 knockdown alleviates inflammation and fibrosis in myocardial infarction through promoting ZCCHC9 expression and blocking the p38 MAPK signaling. Biochem Genet. 2025;63(5):4566\u201386.","journal-title":"Biochem Genet"},{"issue":"3","key":"3203_CR36","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1189\/jlb.3A0514-254RR","volume":"97","author":"I Naegelen","year":"2015","unstructured":"Naegelen I, Plan\u00e7on S, Nicot N, Kaoma T, Muller A, Vallar L, et al. An essential role of syntaxin 3 protein for granule exocytosis and secretion of IL-1\u03b1, IL-1\u03b2, IL-12b, and CCL4 from differentiated HL-60 cells. J Leukoc Biol. 2015;97(3):557\u201371.","journal-title":"J Leukoc Biol"},{"issue":"21","key":"3203_CR37","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1182\/blood-2018-02-835561","volume":"131","author":"JH Rowe","year":"2018","unstructured":"Rowe JH, Delmonte OM, Keles S, Stadinski BD, Dobbs AK, Henderson LA, et al. Patients with CD3G mutations reveal a role for human CD3\u03b3 in Treg diversity and suppressive function. Blood. 2018;131(21):2335\u201344.","journal-title":"Blood"},{"issue":"31","key":"3203_CR38","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.3748\/wjg.v13.i31.4207","volume":"13","author":"N-N Pawlowski","year":"2007","unstructured":"Pawlowski N-N, Struck D, Grollich K, Kuhl A-A, Zeitz M, Liesenfeld O, et al. CD2 deficiency partially prevents small bowel inflammation and improves parasite control in murine Toxoplasma gondii infection. World J Gastroenterol. 2007;13(31):4207\u201313.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"3203_CR39","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.amjms.2020.05.005","volume":"360","author":"Y Aso","year":"2020","unstructured":"Aso Y, Kase M, Sagara M, Sakurai S, Iijima T, Tomaru T, et al. Teneligliptin, a DPP-4 inhibitor, decreases plasma levels of inflammatory chemokines during a standard meal test in patients with type 2 diabetes. Am J Med Sci. 2020;360(3):261\u20137.","journal-title":"Am J Med Sci"},{"issue":"1","key":"3203_CR40","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41420-021-00625-7","volume":"7","author":"X Wang","year":"2021","unstructured":"Wang X, Ke J, Zhu Y-J, Cao B, Yin R-L, Wang Y, et al. Dipeptidyl peptidase-4 (DPP4) inhibitor sitagliptin alleviates liver inflammation of diabetic mice by acting as a ROS scavenger and inhibiting the NF\u03baB pathway. Cell Death Discov. 2021;7(1):236.","journal-title":"Cell Death Discov"},{"issue":"4","key":"3203_CR41","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1538\/expanim.16-0037","volume":"65","author":"M Maeda","year":"2016","unstructured":"Maeda M, Murakami T, Muhammad N, Inoshima Y, Ishiguro N. Experimental transmission of systemic AA amyloidosis in autoimmune disease and type 2 diabetes mellitus model mice. Exp Anim. 2016;65(4):427\u201336.","journal-title":"Exp Anim"},{"issue":"1","key":"3203_CR42","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cell.2019.11.026","volume":"180","author":"J-Y Lee","year":"2019","unstructured":"Lee J-Y, Hall JA, Kroehling L, Wu L, Najar T, Nguyen HH, et al. Serum amyloid a proteins induce pathogenic Th17 cells and promote inflammatory disease. Cell. 2019;180(1):79\u201391.","journal-title":"Cell"},{"key":"3203_CR43","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cytogfr.2025.03.003","volume":"83","author":"P Papareddy","year":"2025","unstructured":"Papareddy P, Herwald H. From immune activation to disease progression: unraveling the complex role of Serum Amyloid A proteins. Cytokine Growth Factor Rev. 2025;83:77\u201384.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"4","key":"3203_CR44","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1093\/ije\/dyac233","volume":"52","author":"T Jiang","year":"2023","unstructured":"Jiang T, Gill D, Butterworth AS, Burgess S. An empirical investigation into the impact of winner\u2019s curse on estimates from Mendelian randomization. Int J Epidemiol. 2023;52(4):1209\u201319.","journal-title":"Int J Epidemiol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03203-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03203-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03203-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:02:52Z","timestamp":1783044172000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03203-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3203"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03203-2","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The observational clinical study of LADA was conducted according to the ethical policies and procedures approved by the ethics committee of the Second Xiangya Hospital of Central South University, China (Approval No. 2021-709). Summary-level GWAS datasets used in this study are publicly available. All original GWAS studies were approved by the ethics committee with informed consent from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"191"}}